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Abstract—Background: Extracellular signal-regulated kinase
(ERK) and p38 mitogen-activated protein kinase are tran-
siently phosphorylated (activated) in the spinal cord and tri-
geminal nucleus by acute noxious stimuli. Acute stimulation
of dental pulp induces short-lived ERK activation in trigem-
inal subnucleus caudalis (Vc), and p38 inhibition attenuates
short-term sensitization in Vc induced by acute pulpal stim-
ulation. We have developed a model to study central
changes following chronic inflammation of dental pulp that
induces long-term sensitization. Here, we examine the
effects of chronic inflammation and acute stimulation on
the expression of phosphorylated ERK (pERK), phosphory-
lated p38 (pp38) and Fos in Vc.
Results: Chronic inflammation alone induced bilateral
expression of pERK and pp38 in Vc, but did not induce
Fos expression. Stimulation of both non-inflamed and
inflamed pulps significantly increased pERK and pp38 bilat-
erally; expression was greatest in inflamed, stimulated ani-
mals, and was similar following 10-min and 60-min
stimulation. Stimulation for 60 min, but not 10 min, induced
Fos in ipsilateral Vc; Fos expression was significantly
greater in inflamed, stimulated animals. pERK was present
in both neurons and astrocytes; pp38 was present in neu-
rons and other non-neuronal, non-astrocytic cell types.
Conclusions: This study provides the first demonstration
that chronic inflammation of tooth pulp induces persistent
bilateral activation of ERK and p38 within Vc, and that this
activation is further increased by acute stimulation. This
altered activity in intracellular signaling is likely to be linked
to the sensitization that is seen in our animal model and in
patients with pulpitis. Our data indicate that pERK and pp38
aremoreaccuratemarkersof central change thanFosexpres-
sion. In our model, localization of pERK and pp38 within spe-
cific cell types differs from that seen following acute
stimulation. This may indicate specific roles for different cell
types in the induction and maintenance of pulpitic and other
types of pain. 2014 The Authors. Published by Elsevier Ltd.
on behalf of IBRO. This is an open access article under theCC
BY license (http://creativecommons.org/licenses/by/3.0/).
Key words: pERK, pp38, MAPK, chronic inflammation, pain,
trigeminal nucleus.
INTRODUCTION
Evidence indicates that altered activity in intracellular
signaling cascades plays a signiﬁcant role in altered
excitability and sensitization in the spinal cord and
trigeminal nucleus, and this activity has been implicated
in the development of pain. The mitogen-activated
protein kinases (MAPKs) extracellular signal-regulated
kinase (ERK) and p38 MAPK are phosphorylated
(activated) in the spinal cord and trigeminal nucleus by
noxious stimulation. It is also well established that the
proto-oncogene c-fos and its protein product Fos can be
rapidly induced in these regions by peripheral noxious
stimulation. Thus, these molecules have been widely
used as correlates of activity related to nociception.
Although Fos, phosphorylated ERK (pERK) and
phosphorylated p38 (pp38) are induced by a range of
peripheral stimuli, the time course of expression of
these molecules varies widely according to the stimulus.
For example a number of studies have described
relatively short-term increases (peak 2–20 min, returning
to baseline levels at 2 h) in levels of pERK following
the application of a number of acute noxious stimuli
including electrical, thermal, mechanical, and chemical
stimulation (mustard oil, capsaicin, and carrageenan) (Ji
et al., 1999, 2002; Galan et al., 2002; Pezet et al.,
2002). A study in the trigeminal system (Huang et al.,
2000) describes increased numbers of pERK-immunore-
active (IR) neurons in ipsilateral trigeminal subnucleus
caudalis (Vc) 1 h after formalin injection into the peri-oral
skin. However, some studies in models of chronic inﬂam-
mation have found that increased pERK levels are main-
tained for long periods under these conditions. For
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example, increased levels of pERK still persist 7 days
after injection of complete Freund’s adjuvant (CFA) into
the hind paw (Adwanikar et al., 2004), whereas a study
in a neuritis model (Kominato et al., 2003) demonstrated
that pERK (and Fos) was not increased in animals with
neuritis alone but, following noxious stimulation (pinch) 3
and 7 days after induction of neuritis, levels of pERK
(and Fos) were greater in animals with neuritis than in
control animals.
The MAPK p38 is also activated by a variety of
acute stimuli including injection of intraplantar formalin
and intrathecal substance P (Svensson et al., 2003).
This increase in activity is short lived (present at
5 min, returning to baseline by 20 min). More persistent
activation of p38 has also been reported in other mod-
els, for example ligation of L5 spinal nerve results in
activation of p38 starting within 1 day of the lesion which
persists for longer than 3 weeks (Jin et al., 2003). Unlike
the increases in pERK, p38 activation has generally
been reported in glia rather than neurons (Ji et al.,
2009). This increase in p38 activity has also been linked
to neuronal Fos expression as p38 MAPK inhibition pre-
vented Fos expression (and attenuated hyperalgesia)
following intraplantar formalin injection (Svensson
et al., 2003).
We have developed a model to study central
changes following chronic inﬂammation of the dental
pulp in the ferret and have examined Fos expression
in the trigeminal nucleus following electrical tooth pulp
stimulation in animals with normal and inﬂamed tooth
pulps (Oakden and Boissonade, 1998; Worsley et al.,
2007, 2008). In this model, unlike that reported in mod-
els of acute pulpal inﬂammation (e.g. stimulation with
lipopolysaccharide (Chattipakorn et al., 2002)), we do
not see Fos protein expressed under conditions of
inﬂammation alone. However when the inﬂamed pulp is
electrically stimulated 5 days post induction of inﬂamma-
tion, Fos expression is signiﬁcantly greater than that
seen following similar stimulation of the non-inﬂamed
pulp (Worsley et al., 2007, 2008). This indicates that in
this model although the inﬂammation alone does not
induce Fos expression, it does induce long-term sensiti-
zation. Previous studies have shown that acute stimula-
tion of the dental pulp induces short-lived ERK activation
in the trigeminal nucleus (Shimizu et al., 2006), but this
was shown to return to baseline levels 2 h post stimulus.
It has also been demonstrated that inhibition of p38 can
attenuate central sensitization in Vc nociceptive neurons
induced by acute noxious stimulation of the tooth pulp
with mustard oil (Xie et al., 2007). However it is not
yet established whether these molecules are activated
for longer time periods in chronic pulpal inﬂammation,
such as that which occurs in patients with pulpal inﬂam-
matory pain.
Persistent activation of these molecules in our model
of chronic pulpal inﬂammation could contribute to the
increased Fos expression seen following stimulation of
inﬂamed tooth pulp. Thus our model provides an
excellent opportunity to identify central changes in
MAPK activation that may play a role in central
sensitization within the trigeminal system.
The aim of this study was to determine the eﬀect of
chronic inﬂammation on expression of pERK, pp38 and
Fos. We compared expression of pERK, pp38 and Fos
in animals with non-inﬂamed and chronically inﬂamed
pulps, and examined their expression following electrical
stimulation (for 10 or 60 min) of the tooth pulp in both
groups of animals. In some sections, we carried out
dual labeling to examine colocalization of pERK and
pp38 with the neuronal marker neuron-speciﬁc nuclear
protein (NeuN) and the astrocyte marker glial ﬁbrillary
acidic protein (GFAP).
This paper reports that chronic inﬂammation of the
tooth pulp induces signiﬁcant and persistent bilateral
expression of pERK and pp38 in Vc. The pERK is
present in neurons and astrocytes, while the pp38 is
seen in neurons and other non-neuronal, non-astrocytic
cell types.
EXPERIMENTAL PROCEDURES
Experiments were carried out in 32 adult female ferrets
(5–8 months old; Highgate Farm, UK), under UK Home
Oﬃce Licence regulation and approval. The ferrets were
prepared under anesthesia (ketamine, Fort Dodge,
Southampton, UK; 25 mg/kg; xylazine, Bayer, Newbury,
UK; 2 mg/kg; intramuscularly) in order to allow tooth
pulp inﬂammation and stimulation of the upper and
lower left canine teeth, and an electromyogram (EMG)
to be recorded from the digastric muscle during a
subsequent experiment. Brieﬂy, a connector block
composed of a mini 9-way socket and an intravenous
injection port was attached to the skull. Leads from this
block were passed subcutaneously to insulated Ag–
AgCl ﬁllings in the left canine teeth for stimulation, and
to the left digastric muscle for recording its EMG. A
cannula from the injection port was inserted into the left
jugular vein. Following cannula insertion anesthesia was
maintained intravenously, using alfaxalone (Ve´toquinol;
Buckingham, UK) at 6 mg/kg/h. These procedures have
been described in greater detail previously (Oakden and
Boissonade, 1998; Worsley et al., 2007). In 16 of these
animals, pulpal inﬂammation was induced by the introduc-
tion of human caries into deep buccal cavities in the upper
and lower left canine teeth as described previously
(Worsley et al., 2007).
Five days later the animals were anesthetized with
alfaxalone (4 mg/kg) via the indwelling cannula. Light
anesthesia was then maintained by continuous infusion
of alfaxalone (4–14 mg/kg/h), adjusted to allow a
withdrawal reﬂex to be seen following a paw squeeze.
Body temperature was maintained at 38 ± 0.5 C. In 16
animals (non-inﬂamed n= 8, inﬂamed n= 8) the tooth
pulps were electrically stimulated via the tooth
electrodes (a train of three 0.5-ms duration stimuli at
200 Hz) and the amplitude of the stimulus required to
produce the jaw-opening reﬂex (JOR) was determined
for each tooth. The tooth pulps were then stimulated at
ten times the JOR threshold, once per second for either
10 min (non-inﬂamed n= 4, inﬂamed n= 4) or 60 min
(non-inﬂamed n= 4, inﬂamed n= 4). The remaining 16
animals were kept under anesthesia for either 10 min
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(non-inﬂamed n= 4, inﬂamed n= 4) or 60 min (non-
inﬂamed n= 4, inﬂamed n= 4). All animals were then
immediately deeply anesthetized with sodium
pentobarbitone (Sagatal; Rhone Merieux, Harlow, UK;
42 mg/kg, intraperitoneally) and perfused with 1000 ml
of phosphate-buﬀered saline (PBS), followed by 1000 ml
of 4% paraformaldehyde ﬁxative.
Following perfusion brainstems were removed, post-
ﬁxed in paraformaldehyde for 4 h at 4 C and immersed
in a 30% sucrose solution overnight for cryoprotection.
Immunohistochemistry
Following overnight immersion in sucrose solution the
brainstems were marked along the ventral surface to
allow identiﬁcation of the left and right sides. They were
then embedded in optimum cutting temperature medium
(OCT; Tissue Tek, UK) and stored at 80 C until cut.
Frozen serial sections (30 lm) were cut from 5 mm
caudal to 10 mm rostral to obex (the point at which the
central canal opens up into the fourth ventricle).
Sections were collected in four sets, generating 120 lm
between adjacent sections in each set. Sets 1–3 were
processed immunohistochemically for Fos, pERK and
pp38. The fourth set was used for double labeling of
pERK or pp38, with either the neuronal marker NeuN or
the astrocyte marker GFAP.
Single labeling of Fos, pERK and pp38. The ﬁrst set of
tissue was processed for Fos immunohistochemistry, as
described previously (Worsley et al., 2007). The second
and third sets were processed for pERK and pp38,
respectively. In order to reduce background staining the
sections were placed in 10% normal goat serum (NGS;
Vector Laboratories, Peterborough, UK) made up in
PBS containing 0.2% Triton X-100 (PBST) for 1 h. They
were then incubated at 4 C for 48 h with primary antibod-
ies raised in rabbit to one of: Fos (1:20,000; Calbiochem,
San Diego, CA, USA); pERK (1:600 [#9101]; Cell Signal-
ing Technology, Danvers, MA, USA), or pp38 (1:300
[#9211]; Cell Signaling Technology) (see Table 1). In all
cases, the primary antibodies were made up in PBST
containing 5% NGS. The sections were then washed
twice with PBS and incubated for 30 min at room temper-
ature with a biotinylated anti-rabbit antibody raised in goat
(1:300; Vector Laboratories, UK), made up in PBST con-
taining 1.5% NGS. The labeling was visualized using the
avidin–biotin complex (ABC) method with nickel-intensi-
ﬁed diaminobenzidine (DAB) as the chromagen, as
described previously (Worsley et al., 2007). Immunohisto-
chemical controls were performed using liquid phase pre-
absorption of the relevant primary antibody with the Fos
peptide (Calbiochem), pERK peptide (#1150; Signaling
Technology) or pp38 peptide (#1170; Cell Signaling
Technology).
Double labeling. Sections from the fourth set of tissue
were used for dual-labeling of pERK or pp38, with either
NeuN or GFAP to identify cell types expressing pERK
or pp38.
In order to reducebackground staining, the sectionswere
ﬁrst placed in 10% normal donkey serum (NDS; Vector
Laboratories, UK) made up in PBST for 1 h. Sections were
then incubated for 24 h with primary antibodies raised in
rabbit to one of pERK or pp38 (as above and at the same
dilutions as for the single labeling studies), together with
mouse monoclonal primary antibodies to either NeuN
(1:500; Abcam, Cambridge, UK) or GFAP (1:300; Vector
Laboratories, UK) (Table 1). Primary antibodies were
diluted in PBST containing 5% NDS.
After washing with PBS, sections were incubated for
2 h with indocarbocyanine (Cy3)-labeled donkey anti-
rabbit, together with ﬂuorescein isothiocyanate (FITC)-
labeled donkey anti-mouse secondary antibodies (both
1:500; Jackson ImmunoResearch, Newmarket, UK),
diluted in PBST containing 2% NDS. Thus pERK and
pp38 labeling were visualized with Cy3, and NeuN and
GFAP labeling were visualized with FITC.
Negative controls for the monoclonal antibodies to
NeuN and GFAP were performed where the primary
antibodies were omitted and the tissue incubated with
NDS and the FITC-labeled secondary antibody only.
Analysis
Sectionswere viewed using a Zeiss Axioplan 2microscope
equipped for ﬂuorescence imaging, and Image Pro-Plus
(v5.1, Media Cybernetics, Rockville, MD, USA) was used
for image capture and analysis. Fos, pERK and pp38
immunohistochemistry was examined in seven sections
at 120-lm intervals from 1800 lm caudal to 1080 lm
caudal to obex. All slides were blinded prior to
experimental analysis, and all quantiﬁcation was
undertaken by the same investigator and repeated on
Table 1. Primary and secondary antisera
Host and type Dilution Supplier
Antigen
Fos Rabbit polyclonal 1:20,000 Calbiochem, USA
pERK Rabbit polyclonal [#9101] 1:600 Cell Signaling Technology, USA
pp38 Rabbit polyclonal [#9211] 1:300 Cell Signaling Technology, USA
NeuN Mouse monoclonal 1:500 Abcam, UK
GFAP Mouse monoclonal 1:300 Vector Laboratories, UK
Secondary label
Biotin Goat anti-rabbit 1:300 Vector Laboratories, UK
Cy3 Donkey anti-rabbit 1:500 Jackson ImmunoResearch, UK
FITC Donkey anti-mouse 1:500 Jackson ImmunoResearch, UK
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10% of samples on a diﬀerent day. These repeat
measurements were within a 5% margin of the ﬁrst count.
Fos. The Fos-positive nuclei in Vc, on both the
contralateral (unstimulated, right) and ipsilateral
(stimulated, left) sides of the brainstem were counted at
the seven levels described above. Statistical
comparisons of total Fos counts between treatment
groups were made using the unpaired Student’s t-test.
pERK and pp38. Computerized image analysis of
labeling was carried out using Image-Pro Plus v5.1
computer software (Media Cybernetics, USA) to quantify
the percentage area of labeling for each of the
molecules. We used an area of interest (AOI) tool to
generate a series of areas that outlined the region in the
outer laminae of Vc where Fos was expressed following
pulpal stimulation (examples of these outlines are
shown in Fig. 2). Outlines were made for each of the
A B
C D
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G H
Fig. 1. pERK and pp38 antibodies: preabsorption controls. Photomicrographs illustrating (A–D) pERK and (E–H) pp38 immunohistochemistry in
subnucleus caudalis. Preabsorption of the pERK and pp38 antibodies with the respective peptides abolished immunoreactivity (B, D, F, H). Scale
bar = 100 lm (C, D, G, H); 50 lm (A, B, E, F).
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seven levels where Fos expression was quantiﬁed. These
AOIs were superimposed onto captured images of pERK
and pp38 labeling from equivalent rostro–caudal regions
of Vc. The percentage area of the AOI that contained
labeling for pERK and pp38 was calculated and an
average of the seven levels used as the value for each
animal.
Statistics. Statistical comparison of areas expressing
pERK and pp38 were made between diﬀerent treatment
groups using a two-way analysis of variance (ANOVA).
These comparisons demonstrated a highly signiﬁcant
eﬀect of inﬂammation, thus the unpaired Student’s t-test
was used to compare non-stimulated, non-inﬂamed vs.
non-stimulated, inﬂamed groups; and stimulated, non-
inﬂamed vs. stimulated, inﬂamed groups.
As Fos was only expressed in the groups stimulated
for 60 min, statistical comparisons of Fos counts were
made between the 60-min stimulated, non-inﬂamed and
60-min stimulated, inﬂamed groups using the unpaired
Student’s t-test.
A value of p< 0.05 was considered signiﬁcant in all
statistical tests.
RESULTS
pERK and pp38 immunoreactivity was present in
subnucleus caudalis in all groups and was abolished by
preabsorption of the antibodies with their respective
peptides (Fig. 1). Preabsorption of the Fos antibody
with its respective peptide also abolished Fos
immunoreactivity, as described previously (Bowler et al.,
2013).
Fos labeling
Fos labeling was only present in the trigeminal nucleus of
the two groups of animals that had received pulpal
stimulation for 60 min. As expected, no Fos was present
in the groups of animals that were perfused after 10 min
of pulpal stimulation; this is in keeping with previous
studies showing that Fos ﬁrst appears 20 min after the
application of a stimulus. As described in our previous
A B
C D
E F
Fig. 2. Fos immunohistochemistry in subnucleus caudalis from animals with stimulated and/or inﬂamed tooth pulps. Photomicrographs showing
Fos-positive staining in ipsilateral subnucleus caudalis (1800 lm caudal to obex). (A) non-stimulated, non-inﬂamed; (B) non-stimulated, inﬂamed;
(C) stimulated (60 min), non-inﬂamed; (D) stimulated (60 min), inﬂamed; (E) and (F) images from (C) and (D) outlining regions where Fos-positive
cells were counted. Scale bar = 100 lm.
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study (Worsley et al., 2007) there was also very little Fos
in non-stimulated animals with either normal or inﬂamed
pulps (Fig. 2). When present, Fos-positive proﬁles were
concentrated on the left side (ipsilateral to pulpal stimula-
tion) of the trigeminal nucleus with very little Fos labeling
in the contralateral brainstem, this is also as described in
our previous studies (Oakden and Boissonade, 1998;
Worsley et al., 2007, 2008; Bowler et al., 2013).
In subnucleus caudalis, Fos expression was seen in
the outer laminae, between 2730 and 930 lm caudal to
obex, peaking at approximately 1530 lm. These
ﬁndings are in agreement with previously published
results and are described in more detail elsewhere
(Oakden and Boissonade, 1998; Worsley et al., 2007,
2008; Bowler et al., 2013).
Following 60 min of stimulation, Fos-positive proﬁles
appeared more numerous in animals with inﬂamed
pulps than in those with non-inﬂamed pulps (Fig. 2C, D).
Quantiﬁcation of these proﬁles revealed that total Fos
expression in Vc was signiﬁcantly greater in animals
with inﬂamed pulps (mean 368.0 ± 17.8 [SEM] cells)
than in those with non-inﬂamed pulps (mean
147.8 ± 22.6 [SEM] cells; p= 0.0003, unpaired t-test;
Fig. 3).
pERK and pp38 labeling
Labeling for pERK and pp38 appeared similar on both
right and left sides of the brainstem (i.e., ipsilateral and
contralateral to the prepared teeth). Expression of pERK
and pp38 was concentrated in the outer laminae
(Figs. 4 and 6) both ipsilaterally and contralaterally, in a
similar region to that where Fos expression was seen
ipsilaterally. Labeling was present in proﬁles
representing both cell bodies and processes (Fig. 1).
Expression of pERK and pp38 was very low in non-
stimulated animals with non-inﬂamed pulps, and levels
of expression appeared highest in stimulated animals
with inﬂamed pulps. There appeared to be little
diﬀerence in levels of pERK and pp38 between animals
receiving either 10 or 60 min of stimulation.
Figs. 5 and 7 show the mean percentage areas of
pERK and pp38 expression in Vc. Percentage area of
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Fig. 3. Mean total Fos counts in subnucleus caudalis. Mean total Fos
count in both ipsilateral and contralateral subnucleus caudalis of
animals with non-inﬂamed or inﬂamed tooth pulps, either
non-stimulated or stimulated for 60 min. h= non-stimulated,
non-inﬂamed; = non-stimulated, inﬂamed; = stimulated, non-
inﬂamed;j= stimulated, inﬂamed. Each bar represents the average
total Fos count of seven sections in the area 1800–1080 lm caudal to
obex. ⁄⁄⁄p< 0.001; unpaired t-test.
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C D
Fig. 4. Examples of pERK immunoreactivity in subnucleus caudalis. Photomicrographs showing examples of ipsilateral pERK labeling in
subnucleus caudalis (1800 lm caudal to obex). (A) non-stimulated, non-inﬂamed; (B) non-stimulated, inﬂamed; (C) stimulated (10 min), non-
inﬂamed; (D) stimulated (10 min), inﬂamed. Scale bar = 100 lm.
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expression for diﬀerent groups was similar at both 10- and
60-min time points. Mean percentage expression of pERK
and pp38 was lowest in non-stimulated non-inﬂamed
animals and highest in stimulated inﬂamed animals, with
the other two groups having an intermediate degree of
labeling.
A two-way ANOVA demonstrated a highly signiﬁcant
eﬀect of inﬂammation (p< 0.0001 in all cases), and
further pairwise comparisons showed a signiﬁcant eﬀect
of inﬂammation in both non-stimulated and stimulated
groups (p< 0.05 in all cases, unpaired t-test; Figs. 5
and 7). Two-way ANOVA also identiﬁed an additional
but less powerful eﬀect of stimulation (p 6 0.0072 in all
cases).
Double labeling
Some sections were utilized to examine colocalization of
pERK and pp38 with NeuN to label neurons and GFAP
to label astrocytes. Attempts were also made to
investigate expression in microglia by labeling for OX42
and Iba-1, however neither of these antibodies produced
any clear labeling. Both of these markers have been
widely used in rat and mouse but to the authors’
knowledge there are no reports of their use in ferret. It
seems likely that the lack of positive staining in this
study was related to species diﬀerences in microglial
cells.
Labeling for pERK was colocalized with NeuN in
animals that had been stimulated (Figs. 8A–C).
However in animals with inﬂamed pulps, a large
proportion of pERK labeling was colocalized with GFAP
(Figs. 8D–F). pERK-positive cells with clear neuronal
proﬁles that did not express GFAP were also seen
(Figs. 8G–I).pp38 was also found to be present in
neurons (Figs. 9A–F); qualitatively, there appeared to
be more labeled neurons in animals with stimulated
inﬂamed pulps (Figs. 9D–F). Labeling for pp38 was also
present in other cells and terminals not labeled by
NeuN, and no colocalization was seen with GFAP
(Figs. 9G–I) following either inﬂammation or stimulation.
This suggests that labeling not colocalized with NeuN
was in microglial cells.
DISCUSSION
In this study we have compared the expression of Fos,
pERK and pp38 following chronic tooth pulp
inﬂammation and acute stimulation. As demonstrated in
our previous work (Worsley et al., 2007), the study
showed that chronic inﬂammation of the pulp alone did
not induce Fos expression, but Fos expression was
increased following stimulation in animals with inﬂamed
teeth. However, the expression of both pERK and pp38
displayed a diﬀerent pattern to that of Fos. Chronic inﬂam-
mation alone or stimulation alone increased bilateral
expression of these molecules in Vc, and expression
was further increased in animals that were both stimu-
lated and inﬂamed. The lack of Fos expression following
stimulation alone is in contrast to previous studies that
have used inﬂammatory stimuli to evoke Fos expression
in the trigeminal complex. Inﬂammation of the dental pulp
(Byers et al., 2000; Chattipakorn et al., 2002) or temporo-
mandibular joint (Zhou et al., 1999) has been shown to
increase Fos expression bilaterally in Vc and the transi-
tional regions between subnuclei caudalis and interpolar-
is. As discussed in detail in our previous study (Worsley
et al., 2007), these diﬀerences may be explained by the
use of diﬀerent protocols, species or models.
Time course of pERK and pp38 expression
Our present study demonstrates for the ﬁrst time that
unlike Fos, both pERK and pp38 are present 6 days
following induction of chronic pulpal inﬂammation, even
in the absence of further pulpal stimulation. This
indicates that chronic pulpal inﬂammation produces
altered central activation, which is likely to be linked to
the increased Fos expression seen in animals with
inﬂamed stimulated pulps, compared with that seen in
those with non-inﬂamed stimulated pulps. It has been
clearly established that a wide range of peripheral
stimuli induce activation of ERK and p38 in the dorsal
horn and trigeminal nucleus (Ji et al., 2009). This includes
studies of pERK expression following the application of
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Fig. 5. Mean pERK immunoreactivity in subnucleus caudalis. Mean
percentage area (±SEM) of pERK labeling in subnucleus caudalis
of animals with non-inﬂamed or inﬂamed tooth pulps, either
non-stimulated or stimulated for (a) 10 min or (b) 60 min. h= non-
stimulated, non-inﬂamed; = non-stimulated, inﬂamed; = stimu-
lated, non-inﬂamed;j= stimulated, inﬂamed. The graphs show both
ipsilateral and contralateral sides. Each bar represents the average
percentage area staining of seven sections in the area 1800–
1080 lm caudal to obex. ⁄⁄⁄p< 0.001; ⁄⁄p< 0.01; ⁄p< 0.05;
unpaired t-test.
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capsaicin to the tooth pulp (Shimizu et al., 2006); however
this previous study showed only very transient activation
of pERK that was maximal at 5 min and back to baseline
levels at 2 h following stimulation. It may not be appropri-
ate to draw comparisons between the time course of ERK
activation in this and the current study as capsaicin appli-
cation is an acute stimulus, but it does highlight major dif-
ferences in longevity of altered central signaling in a range
of models of inﬂammatory and neuropathic pain.
Other studies have also indicated that following
induction of inﬂammation, expression of pERK and pp38
is relatively short lived, even following application of
stimuli that induce relatively long-term inﬂammatory
changes. For example, following injection of CFA into
the hind paw, pERK is only transiently expressed in the
dorsal horn (peaking at 10 min and reverting to baseline
levels by 2 days), despite the presence of on-going
peripheral inﬂammation, heat hyperalgesia and
mechanical allodynia (Ji et al., 1999; Gao and Ji, 2010).
However, in a number of studies of inﬂammatory pain,
pERK expression has been shown to be increased for
longer time periods post-induction of inﬂammation. For
example, a study in the trigeminal system examined
pERK expression following injection of CFA into the ton-
gue, and reported that levels were still elevated 8 days fol-
lowing induction of inﬂammation (Liu et al., 2012).
Many studies of p38 following inﬂammation show
similar, short-lived activation of this molecule. However
some models of inﬂammation or injury do induce longer-
term expression of pp38 in the spinal cord, including
burn injury (up to 4 weeks) (Chang and Waxman, 2010)
and adjuvant-induced arthritis, where pp38 is expressed
between 8 and 17 days (Boyle et al., 2006). A further
study of formalin injury has shown that pp38 is expressed
in two stages, the ﬁrst appeared a few minutes after
injection and peaked at 1 h and the second was maximal
3–7 days after injury (Li et al., 2010). In the trigeminal sys-
tem, injection of CFA into the temporomandibular joint
induces expression of pp38 that still persists at 7 days
post injection (Cady et al., 2010).
It is also well established that expression of pERK and
pp38 is increased in the dorsal horn and trigeminal
nucleus following peripheral nerve injury, where
persistent expression has been reported in many
studies. Zhuang and colleagues investigated the time
course of pERK expression following a spinal nerve
ligation injury (Zhuang et al., 2005). Their study showed
that following this injury, pERK levels are rapidly elevated
(within 10 min) and are still raised 3 weeks post injury.
However, in the trigeminal system, ERK activation follow-
ing nerve injury appears less persistent with reports of
maximal expression ranging from 1 day (Terayama
et al., 2011) to 3 days (Shibuta et al., 2012) following
injury. Persistent activation of p38 (detectable at day 1,
maintained for 3 weeks) is known to occur in the spinal
cord following nerve injury (Jin et al., 2003), and in the tri-
geminal nucleus, raised levels of pp38 have also been
reported to be present and to persist for 3–14 days post
nerve injury (Piao et al., 2006; Lee et al., 2011;
Terayama et al., 2011; Daigo et al., 2012).
Thus the time course of expression of these
molecules is highly dependent on the nature of the
stimulus, and this has signiﬁcant implications in terms of
how data from these studies might relate to clinical pain
A B
C D
Fig. 6. Examples of pp38 immunoreactivity in subnucleus caudalis. Photomicrographs showing examples of ipsilateral pp38 labeling in subnucleus
caudalis (1800 lm caudal to obex). (A) non-stimulated, non-inﬂamed; (B) non-stimulated, inﬂamed; (C) stimulated (60 min), non-inﬂamed; (D)
stimulated (60 min), inﬂamed. Scale bar = 100 lm.
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in man. In general, models with close clinical correlates –
including the one used in the present study – appear to
show more sustained elevation of these molecules than
those using acute stimulation. For example, models of
cancer pain have demonstrated sustained elevation of
pERK and pp38, with elevated pERK persisting for
21 days post intra-tibial inoculation with cancer cells
(Wang et al., 2012), and elevated pp38 still present at
14 days post injection of osteosarcoma cells into the
femur (Svensson et al., 2008). Thus it may be that data
from some preclinical models may underestimate the time
course of activation and the potential role of these mole-
cules in pain states in man.
Other stimuli have clear diﬀerential eﬀects on the time
course of activation of ERK and p38, as demonstrated in
a study examining expression of pERK and pp38 in a
model of bee venom-induced inﬂammation and
hyperalgesia (Cui et al., 2008). This stimulus (intraplantar
injection of bee venom) induced ERK activation,
which peaked at 2 min but had returned to baseline levels
by 48 h; whereas p38 activation ﬁrst appeared at 1 h,
peaked at 3 days and was still present 7 days after
stimulation.
Bilateral expression of pERK and pp38
In the present study both pERK and pp38 were present
bilaterally and levels of expression were similar in both
ipsi- and contralateral Vc, whereas Fos expression was
only present ipsilateral to pulpal stimulation. Previous
studies of acute pulpal stimulation with capsaicin also
report bilateral expression of pERK in Vc (Shimizu et al.,
2006); however in contrast to the present study, these
authors also report bilateral Fos expression following this
stimulus. Bilateral expression of pERK and pp38 is not
generally seen in the spinal cord, but has been reported
in response to some stimuli, including burn injury
(Chang and Waxman, 2010) and in a model of cancer-
induced pain (Wang et al., 2012). It has been postulated
that these contralateral changes are linked to the develop-
ment of contralateral allodynia. A recent study of over
2000 patients with referred dental pain reported that
15% of these patients had pain referred to the opposite
side (Hashemipour and Borna, 2014). It is plausible that
contralateral changes in pERK and pp38 expression
may be involved in such contralateral changes in sensitiv-
ity in patients with pulpal inﬂammation.
Colocalization with NeuN and GFAP
This study did not quantify colocalization of pERK and
pp38 in diﬀerent cell types, however some interesting
patterns of colocalization were observed. We showed
pERK to be present in both neurons and astrocytes.
Many studies have shown that pERK is expressed in
neurons following application of a range of acute stimuli
(Ji et al., 2009), and the current study found pERK
expression in neurons especially following electrical stim-
ulation. However our study also showed that pERK was
expressed in astrocytes, and this was particularly com-
mon in animals with inﬂamed tooth pulps. Expression
has previously been described in astrocytes in some other
models of inﬂammation and injury. Relatively recent stud-
ies in models of cancer-induced bone pain demonstrated
that pERK was predominantly expressed in astrocytes at
12 and 14 days after inoculation of bone with tumor cells
(Wang et al., 2011, 2012). A previous study of nerve injury
by Zhuang et al. (2005) also showed activation of ERK at
longer time periods after injury, with sequential activation
in neurons, microglia and astrocytes. The authors report
that following injury, pERK in neurons and microglia
peaked at 10 min and 2 days, respectively; at 10 days,
expression was equally present in microglia and astro-
cytes, and by 21 days the majority of labeling was present
in astrocytes. In the trigeminal nucleus, pERK has also
been shown to be present in astrocytes following lingual
nerve injury (Terayama et al., 2011); as in the study by
Zhuang et al. (2005), this study showed a progression
of pERK expression which was seen mostly in microglia
at 1 and 3 days and in astrocytes at 7 days. A role for
astrocytes in orofacial hyperalgesia is also supported by
pharmacological studies of chronic pulpitis and nerve
injury-induced pain in the trigeminal system, which have
shown that modulation of astrocyte activity at 7–14 days
post injury is eﬀective in reversing behavioral responses
and electrophysiological activity indicative of hyperalgesia
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Fig. 7. Mean pp38 immunoreactivity in subnucleus caudalis. Mean
percentage area (±SEM) of pp38 labeling in subnucleus caudalis of
animals with non-inﬂamed or inﬂamed tooth pulps, either non-
stimulated or stimulated for (a) 10 min or (b) 60 min. h= non-
stimulated, non-inﬂamed; = non-stimulated, inﬂamed; = stimu-
lated, non-inﬂamed;j= stimulated, inﬂamed. The graphs show both
ipsilateral and contralateral sides. Each bar represents the average
percentage area staining of seven sections in the area 1800–
1080 lm caudal to obex. ⁄⁄⁄p< 0.001; ⁄⁄p< 0.01; ⁄p< 0.05;
unpaired t-test.
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Fig. 8. Dual labeling of pERK with NeuN and GFAP. Dual labeling of pERK (red) with (A–C) NeuN or (D–I) GFAP (both green); co-localization
appears yellow. Sections in (A–C) and (G–I) stimulated only; section in (D–F) stimulated, inﬂamed. (G–I) shows a higher power photomicrograph of
a single pERK-labeled neuron. Scale bar = 100 lm (A–F); 25 lm (G–I).
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Fig. 9. Dual labelling of pp38 with NeuN and GFAP. Dual labeling of pp38 (red) with (A–F) NeuN or (G–I) GFAP (both green); co-localization
appears yellow. Section in (A–C) inﬂamed only; section in (D–F) stimulated, inﬂamed; section in (G–I) stimulated only. Scale bar = 50 lm.
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and central sensitization (Okada-Ogawa et al., 2009; Lee
et al., 2011; Tsuboi et al., 2011).
Our present study also demonstrated that pp38 was
expressed in neurons, but we did not see any expression
in astrocytes. We were not able to examine pp38
expression in microglia, since – as reported in the results
– neither Iba-1 nor OX42 labeling was successful. Many
studies have reported p38 activation in microglia,
especially following acute stimulation (Wen et al., 2011),
however there are also some previous studies showing
pp38 expression in neurons. This has been reported in a
number of models of pain including postoperative pain
(Huang et al., 2011), adjuvant-induced arthritis (Boyle
et al., 2006), cancer pain (Svensson et al., 2008) and tem-
poromandibular joint inﬂammation (Cady et al., 2010).
These studies using chronic pain models have reported
pp38 in neurons at relatively late time periods, ranging
from 7 to 14 days. A further study has reported pp38
expression in neurons following bee venom injection (Cui
et al., 2008), and this appeared as early as 1 day after
injection and still persisted 7 days after injection.
Together, these studies suggest that sequential
activation of ERK and p38 in diﬀerent cell types may be
a common feature of disease progression. This may be
highly relevant in translating data from preclinical
models to chronic pain conditions in man.
Clinical correlates
It is well documented that patients with pulpitis report
altered sensitivity of the aﬀected teeth. This may
present as spontaneous pain or increased sensitivity,
particularly in response to thermal stimuli. Our group
has developed precise methods to quantify pulpal
sensitivity to thermal stimuli and recent studies have
demonstrated a clear correlation between the presence
of pulpal inﬂammation and increased thermal sensitivity
in man (Barber et al., 2012). Studies from this laboratory
have also shown signiﬁcant correlations between clinical
pain history and altered expression of a variety of mole-
cules within the tooth pulp (Rodd and Boissonade,
2000, 2001; Morgan et al., 2005, 2009). The present
study indicates that as well as these peripheral changes,
long-term central changes in MAPK signaling are present
under conditions of chronic pulpal inﬂammation and both
are likely to play a signiﬁcant role in the generation of clin-
ical pain symptoms.
CONCLUSIONS
This study provides the ﬁrst demonstration that chronic
inﬂammation of the tooth pulp induces signiﬁcant and
persistent bilateral activation of pERK and pp38 within
the trigeminal nucleus, and that expression of these
molecules is further increased by acute stimulation. This
altered activity in intracellular signaling is likely to be
linked to the increased Fos expression that is seen in
the inﬂamed stimulated animals in this and our previous
studies, and is likely to be relevant to the increased
sensitivity that is seen in patients with pulpitis. Data
from this study also indicate that pERK and pp38 are
more accurate markers of central change than Fos
expression. In this model of chronic inﬂammation,
colocalization of pERK and pp38 within speciﬁc cell
types diﬀers from that reported following the application
of acute stimulation. These ﬁndings provide further
evidence for sequential activation of these molecules in
diﬀerent cell types in models of chronic pain, and may
indicate speciﬁc roles for diﬀerent cell types in induction
and maintenance of pulpitic and other types of pain.
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